ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 890 filers reported holding ISHARES TR in Q4 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $244,852 | -0.9% | 1,929 | +0.8% | 0.02% | +14.3% |
| Q1 2023 | $247,157 | -0.8% | 1,914 | +0.8% | 0.01% | -12.5% |
| Q4 2022 | $249,129 | +12.2% | 1,898 | +0.1% | 0.02% | 0.0% |
| Q3 2022 | $222,000 | -0.4% | 1,897 | 0.0% | 0.02% | 0.0% |
| Q2 2022 | $223,000 | +1.4% | 1,897 | +12.4% | 0.02% | +23.1% |
| Q1 2022 | $220,000 | -19.4% | 1,687 | -5.6% | 0.01% | -23.5% |
| Q4 2021 | $273,000 | +33.8% | 1,787 | -4.3% | 0.02% | -64.6% |
| Q2 2019 | $204,000 | -98.7% | 1,868 | -98.6% | 0.05% | -98.6% |
| Q1 2019 | $15,149,000 | +66.8% | 135,504 | +43.9% | 3.37% | +6.2% |
| Q4 2018 | $9,081,000 | -28.7% | 94,174 | -9.9% | 3.17% | -20.5% |
| Q3 2018 | $12,742,000 | +8.3% | 104,498 | -2.4% | 3.99% | +7.4% |
| Q2 2018 | $11,763,000 | +3.9% | 107,111 | +1.0% | 3.71% | -2.2% |
| Q1 2018 | $11,321,000 | +6.3% | 106,064 | +6.3% | 3.80% | +33.2% |
| Q4 2017 | $10,650,000 | – | 99,749 | – | 2.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |